Inventor
PINCUS MATTHEW R
US15 patents
⚠️ This page may combine multiple inventors who share the name “PINCUS MATTHEW R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV NEW YORK STATE RES FOUND
4 patentsUS5624817AApr 29, 1997
Mutations in the gene encoding the alpha chain of platelet glycoprotein Ib
UNIV NEW YORK STATE RES FOUND19 citations91
US5593959AJan 14, 1997
Mutations in the gene encoding the alpha chain of platelet glycoprotein Ib
UNIV NEW YORK STATE RES FOUND19 citations91
US7745405B2Jun 29, 2010
Peptides selectively lethal to malignant and transformed mammalian cells
UNIV NEW YORK STATE RES FOUND9 citations83
US7531515B2May 12, 2009
Peptides selectively lethal to malignant and transformed mammalian cells
UNIV NEW YORK STATE RES FOUND9 citations83
INNAPHARMA INC
3 patentsUS5910478AJun 8, 1999
Peptidomimetics inhibiting the oncogenic action of p21 ras
INNAPHARMA INC20 citations89
US5990172ANov 23, 1999
Peptidomimetics for the treatment of HIV infection
INNAPHARMA INC1 citations50
US5840683ANov 24, 1998
Peptides inhibiting the oncogenic action of p21 ras
INNAPHARMA INC1 citations49
PINCUS MATTHEW R
3 patentsUS8822419B2Sep 2, 2014
Membrane resident peptide in anti-cancer peptides causes tumor cell necrosis rather than apoptosis of cancer cells
PINCUS MATTHEW R7 citations78
US5270215ADec 14, 1993
Colorimetric method for determination of 5-hydroxyindoleacetic acid
PINCUS MATTHEW R2 citations51
US9539327B2Jan 10, 2017
Small molecule cancer treatments that cause necrosis in cancer cells but do not affect normal cells
PINCUS MATTHEW R0 citations46